全球標靶化微脂體藥物傳遞市場規模、佔有率、成長分析（按微脂體類型、應用、標靶化藥物類型）- 產業預測，2024-2031 年

2022年全球標靶化微脂體體給藥市場規模為14.8億美元，從2023年的15.5億美元成長到2031年的22億美元，預測期（2024-2031）預計複合年成長率為4.5%。

由於藥物遞送技術的進步，全球標靶化微脂體藥物遞送市場正在顯著成長。標靶化微脂體提供精確和受控的藥物釋放，減少副作用並提高治療效果。慢性病盛行率的上升和對個人化醫療的需求不斷增加是推動市場擴張的關鍵因素。此外，持續的研發、策略合作夥伴關係以及醫療保健領域不斷增加的投資正在進一步推動市場成長。北美和歐洲受益於強大的醫療基礎設施，而亞太地區由於對醫療進步的興趣增加和不斷成長的患者群體而提供了巨大的商機。值得注意的趨勢包括新型製劑的出現和標靶化治療的探索，凸顯了標靶化微脂體藥物遞送市場的動態和不斷發展的性質。

目錄

執行摘要

• 市場概況
• 繁榮與衰落

調查方法

• 資訊採購
• 次要和主要資料來源
• 市場規模估算
• 市場假設與限制

母市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務

主要市場考察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• Start-Ups分析
• 原料分析
• 創新矩陣
• 研發線產品分析
• 總體經濟指標
• 主要投資分析
• 關鍵成功因素
• 競爭程度

市場動態及前景

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 監管環境
• 波特的分析
• 對未來中斷的特殊考慮

全球標靶化微脂體藥物遞送市場：按微脂體類型

• 市場概況
• 聚乙二醇化微脂體
• 陽離子微脂體
• 陰離子微脂體
• 中性微脂體

全球標靶化微脂體給藥市場：依應用分類

• 市場概況
• 癌症治療
• 感染疾病治療
• 眼科治療
• 心血管疾病的治療
• 其他

全球標靶化微脂體藥物遞送市場：按標靶化藥物類型

• 市場概況
• 化療藥物
• 抗真菌藥物
• 抗生素
• 免疫調節劑
• 其他

全球標靶化微脂體給藥市場規模（按地區）

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2021年）
• 主要市場參與者所採取的策略
• 關鍵成功策略
• 近期市集活動
• 主要企業市場佔有率（2021年）

主要企業簡介

• Alnylam Pharmaceuticals
• Acuity Pharmaceuticals, Inc.
• Jubilant Therapeutics
• Verifor Pharmaceuticals
• BIND Therapeutics
• Paladin Labs
• Lipo Therapeutics
• Pharming Group NV
• Johnson & Johnson Services, Inc.
• Gilead Sciences, Inc.
• Sun Pharmaceutical Industries Ltd.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Janssen Pharmaceuticals, Inc.
• CELSION Corporation
• Abbott
• Ipsen Pharma
• Spectrum Pharmaceuticals, Inc.
• Takeda Pharmaceutical Company Limited
• Roche Holding AG

Global Targeted Liposomes Drug Delivery Market size was valued at USD 1.48 billion in 2022 and is poised to grow from USD 1.55 billion in 2023 to USD 2.20 billion by 2031, growing at a CAGR of 4.5% during the forecast period (2024-2031).

The global Targeted Liposomes Drug Delivery Market is witnessing substantial growth driven by advancements in drug delivery technologies. Targeted liposomes offer precise and controlled drug release, diminishing side effects and enhancing therapeutic effectiveness. The rising prevalence of chronic diseases and the increasing demand for personalized medicine are key factors driving market expansion. Moreover, ongoing research and development efforts, strategic partnerships, and heightened investment in healthcare further propel market growth. Leading in market share, North America and Europe benefit from robust healthcare infrastructure, while the Asia-Pacific region presents lucrative opportunities fueled by a growing focus on healthcare advancements and an expanding patient base. Notable trends include the emergence of novel formulations and the exploration of targeted therapies, underscoring the dynamic and evolving nature of the Targeted Liposomes Drug Delivery Market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Targeted Liposomes Drug Delivery Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Targeted Liposomes Drug Delivery Market Segmental Analysis

The global Targeted Liposomes Drug Delivery market is segmented into four major segments i.e. by By Type of Liposomes, Application, Targeted Drug Type, and region. Based on Type, it is divided into PEGylated Liposomes, Cationic Liposomes, Anionic Liposomes, Neutral Liposomes. Based on Application, it is bifurcated as Cancer Therapy, Infectious Disease Treatment, Ophthalmological Treatment, Cardiovascular Disease Treatment, Other Therapeutic Areas. Based on Targeted Drug Type it is segregated into, Chemotherapy Drugs, Antifungal Drugs, Antibiotic Drugs, Immunomodulatory Drugs, Other Drug Types. Based on region, the market is segmented into United States, Canada, and Mexico.

Drivers of the Global Targeted Liposomes Drug Delivery Market

The increasing need for customized and precise pharmaceuticals highlights the significant role of focused liposomes as essential drug delivery agents. These specialized carriers enable precise and controlled release, effectively reducing side effects and enhancing therapeutic effectiveness. With the rising prevalence of chronic conditions, notably cancer, there's a heightened focus on advanced drug delivery methods such as targeted liposomes.

Restraints in the Global Targeted Liposomes Drug Delivery Market

One of the key obstacles in the market revolves around the elevated costs associated with cutting-edge liposomal formulations and technologies, potentially impeding widespread accessibility. Moreover, regulatory intricacies and varying approval processes across different regions compound these challenges, potentially prolonging the introduction of new liposomal products into the market.

Market Trends of the Global Targeted Liposomes Drug Delivery Market

The growing emphasis on personalized medicine is driving the exploration of customized liposomal formulations tailored to individual patient needs. Continuous advancements in liposomal technology, including the creation of intelligent and stimuli-responsive liposomes, underscore the industry's commitment to enhancing drug delivery accuracy, reflecting a concerted effort towards precision medicine.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Targeted Liposomes Drug Delivery Market by Type of Liposomes

• Market Overview
• PEGylated Liposomes
• Cationic Liposomes
• Anionic Liposomes
• and Neutral Liposomes

Global Targeted Liposomes Drug Delivery Market by Application

• Market Overview
• Cancer Therapy
• Infectious Disease Treatment
• Ophthalmological Treatment
• Cardiovascular Disease Treatment
• and Other Therapeutic Areas

Global Targeted Liposomes Drug Delivery Market by Targeted Drug Type

• Market Overview
• Chemotherapy Drugs
• Antifungal Drugs
• Antibiotic Drugs
• Immunomodulatory Drugs
• and Other Drug Types

Global Targeted Liposomes Drug Delivery Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Alnylam Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acuity Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verifor Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIND Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Paladin Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lipo Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharming Group N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CELSION Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ipsen Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments